First Tracks Biotherapeutics, Inc. (TRAX)
Nasdaq: TRAX · Pharmaceutical Preparations · filing with the SEC since 2026
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.| Fiscal quarter | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|
| Period ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 |
| Report filed | Nov 3, 2026 | Aug 12, 2026 | May 14, 2026 |
| Research and development | 23,846 | 25,644 | 33,955 |
| General and administrative | 8,998 | 9,293 | 18,856 |
| Total operating expenses | 32,844 | 34,937 | 52,811 |
| Operating income | -32,844 | -34,937 | -52,811 |
| Interest and investment income | 1,495 | 1,564 | 2,328 |
| Other income (expense), net | -7 | -1 | -1 |
| Total non-operating income (expense) | 1,488 | 1,563 | 2,327 |
| Net income | -31,356 | -33,374 | -50,484 |
| Earnings per share, basic | -0.88 | -0.95 | · |
| Earnings per share, diluted | -0.88 | -0.95 | · |
| Weighted average shares, basic | 35,747 | 35,003 | · |
| Weighted average shares, diluted | 35,747 | 35,003 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Each quarter is three months. A fourth quarter prints only where the company tagged its three months on their own; the whole year is in the annual view.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding